Skip to main content

Epidemiology of Pediatric Respiratory Syncytial Virus-Associated Illness in FDA’s Sentinel System

Basic Details
Date Posted
Status
Complete
Health Outcome(s)
respiratory syncytial virus (RSV)
respiratory syncytial virus-associated illness
Description

FDA’s Sentinel System was used to characterize the epidemiology of respiratory syncytial virus-associated illness (RSV-AI) in U.S. children between 1 month and 5 years of age from January 2008 through June 2016. Greater than 80% of cases were managed as outpatients and >50% of hospitalized children, including those requiring intensive care, had no traditional risk factors besides young chronologic age. 

Deliverables (1)
Sentinel Final Report: Epidemiology of Pediatric Respiratory Syncytial Virus-Associated Illness in FDA’s Sentinel System
Additional Details
FDA Center
CDER
Time Period
January 1, 2008 - June 30, 2016
Analysis Type
Descriptive
Population / Cohort
Children 1 month to 5 years of age
Data Sources
Sentinel Distributed Database (SDD)
Related Links
Sentinel Drug Study: Respiratory Syncytial Virus-Associated Illness